Apremilast reverses the profibrotic phenotype of dermal fibroblasts derived from patients with systemic sclerosis and prevents the progression of bleomycin-induced dermal fibrosis in mice
Tomoaki Higuchi(Tokyo Women's Medical University), Yasushi Kawaguchi(Tokyo Women's Medical University)
Cited by 0
Related Papers
A functional SNP in the NKX2.5-binding site of ITPR3 promoter is associated with susceptibility to systemic lupus erythematosus in Japanese population
|Journal of Human Genetics|2008|33
Identification of a significant association of a single nucleotide polymorphism in TNXB with systemic lupus erythematosus in a Japanese population
|Journal of Human Genetics|2007|31
Antifibrotic effects of 2-carba cyclic phosphatidic acid (2ccPA) in systemic sclerosis: contribution to the novel treatment
|Arthritis Research & Therapy|2019|10